Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
7.26
-0.24 (-3.20%)
At close: Jul 24, 2026, 4:00 PM EDT
7.21
-0.05 (-0.69%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of $374.59 million as of July 24, 2026. Its market cap has decreased by -9.91% in one year.
Market Cap
374.59M
Enterprise Value
798.89M
1-Year Change
-9.91%
Ranking
Category
Stock Price
$7.26
ChartMarket Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $374.59M, an increase of 16.77%. That is a compound annual growth rate of 0.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 374.60M | -42.29% |
| Dec 31, 2025 | 649.10M | 25.31% |
| Dec 31, 2024 | 518.00M | 316.06% |
| Dec 29, 2023 | 124.50M | -78.87% |
| Dec 30, 2022 | 589.20M | -74.81% |
| Dec 31, 2021 | 2.34B | -50.75% |
| Dec 31, 2020 | 4.75B | 70.50% |
| Dec 31, 2019 | 2.79B | -7.78% |
| Dec 31, 2018 | 3.02B | 57.00% |
| Dec 29, 2017 | 1.92B | 44.63% |
| Dec 30, 2016 | 1.33B | -14.64% |
| Dec 31, 2015 | 1.56B | 52.38% |
| Dec 31, 2014 | 1.02B | 22.29% |
| Dec 31, 2013 | 836.10M | 45.38% |
| Dec 31, 2012 | 575.10M | -5.00% |
| Dec 30, 2011 | 605.40M | -25.67% |
| Dec 31, 2010 | 814.50M | 94.58% |
| Dec 31, 2009 | 418.60M | -46.42% |
| Dec 31, 2008 | 781.20M | 419.07% |
| Dec 31, 2007 | 150.50M | -50.82% |
| Dec 29, 2006 | 306.00M | -4.61% |
| Nov 15, 2006 | 320.80M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 699.02M |
| Ironwood Pharmaceuticals | 610.72M |
| Tilray Brands | 462.82M |
| Aquestive Therapeutics | 461.72M |
| Kamada | 409.11M |
| Evolus | 393.81M |
| Canopy Growth | 380.70M |
| Akebia Therapeutics | 327.28M |